About Noah Nasser
Noah Nasser is a chief executive officer and director at datma.
Form D filings also name Noah Nasser as a director at 3Helix and a chief executive officer and director at Serimmune.
Noah Nasser first appears on SEC filings in 2020.
Experience
This experience comes from Noah Nasser's profile and from SEC filings. For roles taken from filings, the years are when the filings name Noah Nasser in the role, so the role may have started earlier or lasted longer.
3Helix, Inc. Current
Chairperson of the Board
2020 – Present · Salt Lake City, UT
Sells collagen-detecting peptides for laboratory research.
HI
Human Longevity, Inc.
Chief Commercial Officer
2018 – 2019
CO
Counsyl
Chief Commercial Officer at Counsyl
2016 – 2018
AL
AltheaDx
Sr. VP of Sales
2015 – 2016
QU
Quidel
Business Unit Manager, Molecular Diagnostics
1999 – 2011
WD
Wako Diagnostics
Sales Manager
1997 – 1999
Key Colleagues at Startups
The people Noah Nasser works with at each company, as listed on that company's latest Form D.
3Helix, Inc. · Form D, Sep 21, 2026
datma, Inc. · Form D, Jan 3, 2025
Serimmune Inc. · Form D, Aug 11, 2021
BW
Bill Welch
Director
PD
Patrick Daugherty
Director
JS
John Shon
Executive officer
KL
Kristin Loomis
Director
NN
Nicholas Naclerio
Director